Literature DB >> 17087852

Rimonabant--a new weapon in the war on obesity.

Heinrich Taegtmeyer, Thomas R Lux.   

Abstract

Entities:  

Year:  2006        PMID： 17087852     DOI： 10.1007/s11906-006-0019-6

Source DB:  PubMed          Journal:  Curr Hypertens Rep        ISSN： 1522-6417            Impact factor:   5.369


× No keyword cloud information.
  10 in total

1.  Why Syndrome X? From Harold Himsworth to the insulin resistance syndrome.

Authors:  Gerald M Reaven
Journal:  Cell Metab       Date:  2005-01       Impact factor: 27.287

2.  Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery.

Authors:  Lars Sjöström; Anna-Karin Lindroos; Markku Peltonen; Jarl Torgerson; Claude Bouchard; Björn Carlsson; Sven Dahlgren; Bo Larsson; Kristina Narbro; Carl David Sjöström; Marianne Sullivan; Hans Wedel
Journal:  N Engl J Med       Date:  2004-12-23       Impact factor: 91.245

3.  Obesity research--limitations of methods, measurements, and medications.

Authors:  Denise G Simons-Morton; Eva Obarzanek; Jeffrey A Cutler
Journal:  JAMA       Date:  2006-02-15       Impact factor: 56.272

4.  Effects of a Mediterranean-style diet on cardiovascular risk factors: a randomized trial.

Authors:  Ramon Estruch; Miguel Angel Martínez-González; Dolores Corella; Jordi Salas-Salvadó; Valentina Ruiz-Gutiérrez; María Isabel Covas; Miguel Fiol; Enrique Gómez-Gracia; Mari Carmen López-Sabater; Ernest Vinyoles; Fernando Arós; Manuel Conde; Carlos Lahoz; José Lapetra; Guillermo Sáez; Emilio Ros
Journal:  Ann Intern Med       Date:  2006-07-04       Impact factor: 25.391

5.  American Heart Association call to action: obesity as a major risk factor for coronary heart disease. AHA Nutrition Committee.

Authors:  R H Eckel; R M Krauss
Journal:  Circulation       Date:  1998-06-02       Impact factor: 29.690

Review 6.  Clinical Guidelines on the Identification, Evaluation, and Treatment of Overweight and Obesity in Adults--The Evidence Report. National Institutes of Health.

Authors: 
Journal:  Obes Res       Date:  1998-09

7.  Effects of rimonabant on metabolic risk factors in overweight patients with dyslipidemia.

Authors:  Jean-Pierre Després; Alain Golay; Lars Sjöström
Journal:  N Engl J Med       Date:  2005-11-17       Impact factor: 91.245

8.  Treatment of mild to moderate obesity with laparoscopic adjustable gastric banding or an intensive medical program: a randomized trial.

Authors:  Paul E O'Brien; John B Dixon; Cheryl Laurie; Stewart Skinner; Joe Proietto; John McNeil; Boyd Strauss; Sharon Marks; Linda Schachter; Leon Chapman; Margaret Anderson
Journal:  Ann Intern Med       Date:  2006-05-02       Impact factor: 25.391

Review 9.  Obesity and cardiovascular disease: pathophysiology, evaluation, and effect of weight loss: an update of the 1997 American Heart Association Scientific Statement on Obesity and Heart Disease from the Obesity Committee of the Council on Nutrition, Physical Activity, and Metabolism.

Authors:  Paul Poirier; Thomas D Giles; George A Bray; Yuling Hong; Judith S Stern; F Xavier Pi-Sunyer; Robert H Eckel
Journal:  Circulation       Date:  2005-12-27       Impact factor: 29.690

10.  Prevalence of overweight and obesity among US children, adolescents, and adults, 1999-2002.

Authors:  Allison A Hedley; Cynthia L Ogden; Clifford L Johnson; Margaret D Carroll; Lester R Curtin; Katherine M Flegal
Journal:  JAMA       Date:  2004-06-16       Impact factor: 56.272
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.